Matrix Quality Care, Inc. – Trademark Portfolio
Entity Type: 03
Matrix Quality Care, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ARAYA. The owner is based in Latham, NY.
4 British American Boulevard
Latham, NY 12110
Showing of trademarks Trademarks
Trademark Classifications
Matrix Quality Care, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Matrix Quality Care, Inc. have?
Matrix Quality Care, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Matrix Quality Care, Inc. file in?
Matrix Quality Care, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 39 (Transportation & Storage). Class 35 covers advertising; business management; business administration; office functions.
What are Matrix Quality Care, Inc.'s most well-known trademarks?
Matrix Quality Care, Inc.'s registered trademark portfolio includes well-known marks such as ARAYA. These are among 1 currently registered trademark in the portfolio.
What is Matrix Quality Care, Inc.'s trademark registration success rate?
Matrix Quality Care, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.